Trial Profile
Comparison of the Efficacy of Olmesartan Medoxomil Versus Losartan on Diastolic Blood Pressure in Elderly and Very Elderly Patients With Essential Hypertension.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 25 Jun 2018
Price :
$35
*
At a glance
- Drugs Olmesartan medoxomil (Primary) ; Losartan
- Indications Essential hypertension
- Focus Therapeutic Use
- Sponsors Daiichi Sankyo Europe
- 27 Sep 2008 New trial record.